newsfilter
← Latest News
GlobeNewswire·

Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement

GLEN ALLEN, Va., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and